Early response to neoadjuvant chemotherapy in advanced esophageal cancer evaluated by computed tomography predicts the utility of a second cycle of chemotherapy

Multi-course neoadjuvant chemotherapy (NACT) followed by surgery is a promising treatment for advanced esophageal cancer. However, non-responders may continue to receive ineffective treatment, since there are no definitive criteria for early discontinuation of NACT. In this study, we analyzed 103 ad...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: MOTOORI, MASAAKI, YANO, MASAHIKO, YASUDA, TAKUSHI, MIYATA, HIROSHI, PENG, YINGFENG, YAMASAKI, MAKOTO, SHIRAISHI, OSAMU, TANAKA, KOJI, ISHIKAWA, OSAMU, SHIOZAKI, HITOSHI, DOKI, YUICHIRO
Format: Artigo
Langue:Inglês
Publié: D.A. Spandidos 2013
Sujets:
Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3916104/
https://ncbi.nlm.nih.gov/pubmed/24649204
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2013.89
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires